PATH Blog Examines Organization’s Work In Malaria Through Affiliate Drug Development Program
This PATH Blog post examines PATH's work in malaria through OneWorld Health, a non-profit drug development program. Since 2004, "when OneWorld Health formed a partnership to develop an alternative source of the malaria drug artemisinin, ... OneWorld Health, which became an affiliate of PATH late last year, [has] quietly forged relationships with public and private partners, creating the Artemisinin Project to take the work from research to commercialization," the blog writes. "Supported by the Bill & Melinda Gates Foundation, the partners worked toward providing an affordable and reliable source of high-quality artemisinin -- one not dependent on planting schedules, the weather, or the fluctuating market," the blog adds (Donnelly, 4/10).This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.